Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Saad Sirop Kenderian, MD, Ruchi G. Sharma, Mrinal M Patnaik, MD, Timothy G. Call, MD, Shahrukh K Hashmi, MD, Neil E. Kay, MD, Wei Ding, MD, PhD, Mark R. Litzow, MD, Kari G. Rabe, MS, William Hogan, MD, Tait D. Shanafelt, M.D.

Blood (2013) 122 (21): 3375.

https://doi.org/10.1182/blood.V122.21.3375.3375

Published: 2013

Journal Articles

Complex Interstitial Deletions of 11q and Copy-Neutral Loss of Heterozygosity of 11q Are Detected by Whole Genome Copy Number Variation Analysis of Early-Intermediate Stage, High Risk Chronic Lymphocytic Leukemia Patients.

Steven A. Schichman, MD, PhD, Annjanette Stone, BS, Maria Winters, MPH, Weleetka Carter, BS, Lori Frederick, BS, Jeanette Eckel-Passow, Ph.D., Timothy G. Call, MD, Tait D. Shanafelt, M.D., Neil E. Kay, MD, Clive S. Zent, MD, David S. Viswanatha, MD

Blood (2009) 114 (22): 1245.

https://doi.org/10.1182/blood.V114.22.1245.1245

Published: 2009

Journal Articles

Impact of IgVH Gene Mutational Status and VH Family Usage on Chromosomal Aberrations Detected by High-Resolution Array-CGH in B-CLL.

Jose F Leis, MD, PhD, Esteban Braggio, PhD, Scott Van Wier, Jonathan J Keats, PhD, Diane F. Jelinek, PhD, Daniel van Dyke, Clive S. Zent, MD, Tait D. Shanafelt, M.D., Timothy G Call, MD, Neil E. Kay, MD, Rafael Fonseca

Blood (2009) 114 (22): 1246.

https://doi.org/10.1182/blood.V114.22.1246.1246

Published: 2009

Journal Articles

Whole Genome Copy Number Variation Analysis of Chronic Lymphocytic Leukemia (CLL) Cells From Early-Intermediate Stage, High Risk CLL Patients Prior to First Treatment Reveals New Loss of Heterozygosity and Duplication Events in the CLL Genome.

Blood (2009) 114 (22): 1265.

https://doi.org/10.1182/blood.V114.22.1265.1265

Published: 2009

Journal Articles

Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia.

Timothy G Call, MD, Kari G Rabe, MS, Brewer D Jerry, M.D., Neil E. Kay, MD, Clive S. Zent, MD, Susan M Schwager, Deborah A Bowen, FNP, Jose F Leis, MD, Han Tun, MD, Svetomir N Markovic, MD, PhD, Susan L Slager, PhD, Tait D. Shanafelt, M.D.

Blood (2009) 114 (22): 1268.

https://doi.org/10.1182/blood.V114.22.1268.1268

Published: 2009

Journal Articles

Influence of Age at Diagnosis On Utility of Prognostic Testing in Patients with CLL.

Tait D. Shanafelt, M.D., Kari Rabe, Neil E. Kay, MD, Clive S. Zent, MD, Diane F. Jelinek, PhD, Susan Schwager, Deborah Bowen, Susan L Slager, PhD, Megan Reinalda, Curtis A. Hanson, MD, Timothy G Call, MD

Blood (2009) 114 (22): 2342.

https://doi.org/10.1182/blood.V114.22.2342.2342

Published: 2009

Journal Articles

Treatment of Patients with Autoimmune Cytopenia and Progressive CLL Using Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP).

Clive S. Zent, MD, Deborah Bowen, Timothy G Call, MD, Tait D. Shanafelt, M.D., Neil E. Kay, MD, Susan L Slager, PhD, Susan Schwager, Kari Rabe, Megan Reinalda

Blood (2009) 114 (22): 4410.

https://doi.org/10.1182/blood.V114.22.4410.4410

Published: 2009

Journal Articles

Indolent Mantle Cell Lymphoma: A Distinct Subgroup Characterized by Leukemic Phase Disease without Lymphadenopathy.

Dong Chen, MD, PhD, David S. Viswanatha, MD, Clive S. Zent, MD, Tait D. Shanafelt, M.D., Timothy G. Call, MD, Neil E. Kay, MD, Daniel L. Van Dyke, PhD, Rhett P. Ketterling, MD, Thomas E. Witzig, MD, William G. Morice, MD, PhD, Curtis A. Hanson, MD

Blood (2009) 114 (22): 3937.

https://doi.org/10.1182/blood.V114.22.3937.3937

Published: 2009

Journal Articles

Aberrant Regulation of the LEF-1 Locus in Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL): A Possible Role for Epigenetic Regulation.

Albert Gutierrez, Jr., Renee Tschumper, Tait D. Shanafelt, M.D., Jeanette Eckel-Passow, Ph.D., Neil E. Kay, MD, Diane F. Jelinek, PhD

Blood (2009) 114 (22): 669.

https://doi.org/10.1182/blood.V114.22.669.669

Published: 2009

Journal Articles

The Green Tea Extract EGCG Demonstrates Synergist Activity against CLL B-Cells When Combined with Fludarabine and Chlorambucil.

Connie Lesnick, Neil E. Kay, MD, Betsy LaPlant, Tait D. Shanafelt, M.D.,

Blood (2009) 114 (22): 3452.

https://doi.org/10.1182/blood.V114.22.3452.3452

Published: 2009

Journal Articles

D Gene Usage Predicts Clinical Outcome in Patients with Low Rai Risk Unmutated B-CLL.

Renee C. Tschumper, Susan M. Geyer, Ph.D., Megan E. Campbell, Neil E. Kay, M.D., Tait D. Shanafelt, M.D., Clive S. Zent, M.D., Timothy G. Call, M.D., Diane F. Jelinek, Ph.D

Blood (2006) 108 (11): 2779.

https://doi.org/10.1182/blood.V108.11.2779.2779

Published: 2006

Journal Articles

Adaphostin-Induced Apoptosis in CLL B-Cells Is Associated with Induction of Oxidative Stress and Exhibits Synergy with Fludarabine.

Tait D. Shanafelt, M.D., Y. Kit Lee, Nancy D. Bone, Ann K. Strege, Scott H. Kaufmann, M.D., Ph.D., Neil E. Kay, M.D.

Blood (2004) 104 (11): 3482.

https://doi.org/10.1182/blood.V104.11.3482.3482

Published: 2004

NARROW

Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and Is Associated With Pretransplant B Cell Characteristics

Complex Interstitial Deletions of 11q and Copy-Neutral Loss of Heterozygosity of 11q Are Detected by Whole Genome Copy Number Variation Analysis of Early-Intermediate Stage, High Risk Chronic Lymphocytic Leukemia Patients.

Impact of IgVH Gene Mutational Status and VH Family Usage on Chromosomal Aberrations Detected by High-Resolution Array-CGH in B-CLL.

Whole Genome Copy Number Variation Analysis of Chronic Lymphocytic Leukemia (CLL) Cells From Early-Intermediate Stage, High Risk CLL Patients Prior to First Treatment Reveals New Loss of Heterozygosity and Duplication Events in the CLL Genome.

Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia.

Influence of Age at Diagnosis On Utility of Prognostic Testing in Patients with CLL.

Treatment of Patients with Autoimmune Cytopenia and Progressive CLL Using Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP).

Indolent Mantle Cell Lymphoma: A Distinct Subgroup Characterized by Leukemic Phase Disease without Lymphadenopathy.

Aberrant Regulation of the LEF-1 Locus in Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL): A Possible Role for Epigenetic Regulation.

The Green Tea Extract EGCG Demonstrates Synergist Activity against CLL B-Cells When Combined with Fludarabine and Chlorambucil.

D Gene Usage Predicts Clinical Outcome in Patients with Low Rai Risk Unmutated B-CLL.

Adaphostin-Induced Apoptosis in CLL B-Cells Is Associated with Induction of Oxidative Stress and Exhibits Synergy with Fludarabine.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only